Historique
Chapitre
The effectiveness and efficacy of prescribed diacetylmorphine (heroin) in reducing drug-related harm
Auteur(s) :
BOWLES, J. ;
MAGHSOUDI, N. ;
YOUNG, S. ;
GRIFFITHS, S. ;
KOLLA, G.
Année
2023
Page(s) :
48-62
Langue(s) :
Anglais
ISBN :
978-981-5079-25-8
Refs biblio. :
70
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
HEROINE
;
EFFICACITE
;
DISTRIBUTION CONTROLEE
;
PRESCRIPTION MEDICALE
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
TRAITEMENT DE MAINTENANCE
;
INJECTION
;
SURDOSE
Résumé :
Opioid overdoses have dramatically increased throughout the past 20 years. Overdoses and other harms associated with the use of the unregulated opioid supply have resulted in a consortium of approaches to reduce drug-related harms, which for decades has included heroin-assisted treatment, although there remains widespread reticence to implement this approach in spite of ample evidence to support its effectiveness. Heroin-assisted treatment is often reserved for persons who have attempted standard opioid agonist treatments - such as methadone - unsuccessfully in order to be eligible for heroin-assisted treatment in countries and regions where available. To date, heroin-assisted treatment is only available in nine countries, mostly in Europe. Heroin-assisted treatment has higher retention rates than other forms of opioid agonist treatments, is cost-effective, reduces overdose morbidity and mortality, and improves public order. Nonetheless, regulatory structures impede its implementation. The present chapter herein presents further details of the evidence on heroin-assisted treatment and newer treatment modality iterations, such as injectable opioid agonist treatment and safe opioid supply programs.
Affiliation :
Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada
Cote :
L02257